Skip to main content
TipRanks
Go Ultimate75% OFF

BioHarvest Sciences (BHST) Financial Statements

BioHarvest Sciences Financial Overview

BioHarvest Sciences's market cap is currently $128.82M. The company's EPS TTM is $-0.54; its P/E ratio is -7.39; BioHarvest Sciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue$ 34.51M$ 25.19M$ 12.67M$ 5.50M$ 2.10M
Gross Profit$ 20.48M$ 13.94M$ 5.63M$ 1.22M$ 670.00K
Operating Income$ -5.58M$ -6.99M$ -9.97M$ -10.61M$ -8.49M
EBITDA$ -6.71M$ -9.72M$ -9.76M$ -9.13M$ -8.64M
Net Income$ -11.13M$ -12.91M$ -12.56M$ -11.24M$ -9.83M
Balance Sheet
Cash & Short-Term Investments$ 23.02M$ 2.39M$ 5.36M$ 1.74M$ 4.12M
Total Assets$ 47.66M$ 25.00M$ 15.00M$ 9.39M$ 10.21M
Total Debt$ 14.10M$ 13.82M$ 22.34M$ 10.56M$ 2.66M
Net Debt$ -8.92M$ 11.43M$ 16.98M$ 8.82M$ -1.46M
Total Liabilities$ 22.22M$ 23.67M$ 29.86M$ 15.32M$ 7.35M
Stockholders' Equity$ 25.45M$ 1.33M$ -14.85M$ -5.93M$ 2.85M
Cash Flow
Free Cash Flow$ -9.58M$ -9.52M$ -10.00M$ -10.50M$ -8.43M
Operating Cash Flow$ -7.23M$ -6.68M$ -8.52M$ -9.24M$ -6.79M
Investing Cash Flow$ -2.37M$ -3.03M$ -1.47M$ -1.26M$ -1.64M
Financing Cash Flow$ 30.19M$ 6.78M$ 13.56M$ 8.14M$ 10.77M

Currency in USD

BioHarvest Sciences Earnings and Revenue History

-20M020M40M-3000 %-2000 %-1000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

BioHarvest Sciences Liabilities to Assets

020M40M60M0 %600 %1200 %1800 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

BioHarvest Sciences Cash Flow

-20M-10M010M20M30M40M201720182019202020212022202320242025OperatingInvestingFinancing

BioHarvest Sciences Forecast EPS vs Actual EPS

-60-55-50-45-40-35-30Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss